Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$430K Buy
3,577
+197
+6% +$22.7K 0.1% 127
2025
Q4
$356K Buy
3,380
+339
+11% +$31.8K 0.09% 137
2025
Q3
$255K Buy
3,041
+224
+8% +$18.4K 0.06% 163
2025
Q2
$223K Buy
2,817
+372
+15% +$29.6K 0.07% 177
2025
Q1
$219K Sell
2,445
-949
-28% -$88.6K 0.07% 160
2024
Q4
$338K Buy
3,394
+373
+12% +$38.5K 0.11% 133
2024
Q3
$343K Buy
3,021
+30
+1% +$3.56K 0.11% 127
2024
Q2
$370K Buy
2,991
+1,021
+52% +$132K 0.13% 138
2024
Q1
$260K Buy
+1,970
New +$243K 0.09% 157
2023
Q3
Sell
-2,049
Closed -$236K 175
2023
Q2
$236K Sell
2,049
-537
-21% -$61K 0.09% 157
2023
Q1
$275K Buy
2,586
+48
+2% +$5.18K 0.11% 152
2022
Q4
$282K Hold
2,538
0.12% 141
2022
Q3
$218K Sell
2,538
-64
-2% -$5.71K 0.1% 149
2022
Q2
$237K Sell
2,602
-371
-12% -$32.9K 0.1% 156
2022
Q1
$243K Sell
2,973
-95
-3% -$7.49K 0.09% 164
2021
Q4
$235K Sell
3,068
-460
-13% -$36.6K 0.08% 178
2021
Q3
$264K Buy
3,528
+46
+1% +$3.5K 0.1% 170
2021
Q2
$270K Sell
3,482
-334
-9% -$24.8K 0.1% 181
2021
Q1
$280K Sell
3,816
-402
-10% -$29.7K 0.11% 180
2020
Q4
$329K Buy
4,218
+287
+7% +$21.9K 0.13% 171
2020
Q3
$311K Sell
3,931
-91
-2% -$7.13K 0.12% 177
2020
Q2
$296K Sell
4,022
-1,268
-24% -$95.5K 0.13% 168
2020
Q1
$388K Sell
5,290
-2,729
-34% -$214K 0.2% 125
2019
Q4
$695K Buy
8,019
+182
+2% +$14.9K 0.31% 96
2019
Q3
$629K Sell
7,837
-3,563
-31% -$286K 0.29% 104
2019
Q2
$912K Sell
11,400
-811
-7% -$62.1K 0.4% 69
2019
Q1
$969K Sell
12,211
-187
-2% -$14K 0.41% 71
2018
Q4
$904K Sell
12,398
-216
-2% -$15.2K 0.45% 71
2018
Q3
$854K Sell
12,614
-94
-0.7% -$5.99K 0.38% 84
2018
Q2
$736K Buy
12,708
+95
+0.8% +$5.36K 0.35% 102
2018
Q1
$656K Buy
12,613
+8,593
+214% +$464K 0.35% 98
2017
Q4
$216K Buy
+4,020
New +$223K 0.19% 103

Other funds holding MRK

D.B. Root & Company's MRK Position: Q1 2026 in Review

D.B. Root & Company increased its Merck (MRK) stake by 5.8% in Q1 2026, buying an estimated $22.7K and bringing the position to 3,577 shares worth $430K. The position accounts for 0.1% of the portfolio, ranked #127.

D.B. Root & Company first reported a position in MRK in Q4 2017 and has held it in 32 quarters since. The position peaked at $969K in Q1 2019. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • D.B. Root & Company held 3,577 shares of Merck worth $430K as of Q1 2026.
  • D.B. Root & Company bought 197 Merck shares in Q1 2026, an estimated $22.7K.
  • Merck made up 0.1% of D.B. Root & Company's portfolio in Q1 2026, its #127 holding.
  • D.B. Root & Company first reported a position in Merck in Q4 2017 and has held it in 32 quarters since.
  • D.B. Root & Company's Merck position peaked at $969K in Q1 2019.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on D.B. Root & Company's 13F filing for Q1 2026, filed 13 May 2026.